Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
Open Access
- 25 May 2017
- journal article
- research article
- Published by Springer Nature in Hereditary Cancer in Clinical Practice
- Vol. 15 (1) , 7
Abstract
The analysis of relationships of BRCA alterations with cancer at sites other than breast/ovary may provide innovative information concerning BRCA pathogenic role and support additional clinical decisions. Aim of this study is to compare presence of cancers in other sites in members of hereditary (H) and not-hereditary (nH) branches of families of patients eligible to BRCA test. We retrospectively analyzed the incidence of cancer in other sites in members of 136 families eligible for hereditary breast/ovarian cancer genetic counseling at Centro Studi Tumori Eredo-familiari of our Institute; we compared the frequency of other cancer types in 1156 members of the H-branch with respect to 1062 members of nH-Branch. The families belonging to a proband case and with informative members in at least three generation entered the present study. The frequency of other Cancers in members of H-branch was significantly higher than that in members of nH-branch (161 vs 75 cancers; p < 0.0001). In specific, members of H-branch had a significantly higher probability to have more lung cancer (38 vs 9;p < 0.0006), kidney cancer (23 vs 5;p < 0.0005), liver cancer (13 vs 3;p < 0.02) and larynx cancer (14 vs 4;p < 0.03). Interestingly, to belong to H-branch resulted significantly associated with a higher probability of lung cancer (OR 4.5; 2.15–9.38 95%C.I.), liver cancer (OR: 4.02; 1.14–14.15 95% C.I.) and larynx cancer (OR:3.4; 1.12–10.39 95%C.I.) independently from Gender and Age. Members belonging to the H-branch of families of patients eligible to BRCA test have a higher risk of tumors in lung, larynx and liver. Clinicians should consider the increased risk for these cancers to activate prevention/early diagnosis practices in members of families with breast/ovarian familial cancer syndrome.Keywords
This publication has 26 references indexed in Scilit:
- Identification of the deleterious 2080insA BRCA1 mutation in a male renal cell carcinoma patient from a family with multiple cancer diagnoses from PakistanFamilial Cancer, 2011
- Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutationBritish Journal of Cancer, 2008
- BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung CancerPLOS ONE, 2007
- Epigenetic Inactivation of the Chromosomal Stability Control Genes BRCA1, BRCA2, and XRCC5 in Non–Small Cell Lung CancerClinical Cancer Research, 2007
- Role of BRCA1 and BRCA2 mutations in pancreatic cancerGut, 2006
- Breast and Ovarian Cancer in Relatives of Cancer Patients, with and without BRCA MutationsCancer Epidemiology, Biomarkers & Prevention, 2006
- BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, ItalyMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Cancer risks in BRCA2 families: estimates for sites other than breast and ovaryJournal of Medical Genetics, 2005
- Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testingAnnals of Oncology, 2004
- Cancer Incidence in BRCA1 Mutation CarriersJNCI: Journal of the National Cancer Institute, 2002